Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hagyu Kim

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cellular and Molecular Life Sciences : CMLS|September 13, 2023
Revolutionizing control strategies against Mycobacterium tuberculosis infection through selected targeting of lipid metabolismHagyu Kim, Sung Jae Shin
Frontiers in Immunology|June 2, 2020
<i>Mycobacterium tuberculosis</i> Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed TherapyDahee Shim, Hagyu Kim, Sung Jae Shin
Frontiers in Immunology|August 9, 2020
Corrigendum: <i>Mycobacterium tuberculosis</i> Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed TherapyDahee Shim, Hagyu Kim, Sung Jae Shin
NPJ Vaccines|April 10, 2026
An ESAT-6-convergent prime-boost vaccination combining recombinant BCG expressing Mycobacterium marinum ESX-1 and ESAT-6/GLA-SE improves TB protectionKee Woong Kwon, Hongmin Kim, Hagyu Kim, et al.
International Immunopharmacology|April 3, 2024
Adjunctive administration of parabiotic Lactobacillus sakei CVL-001 ameliorates drug-induced toxicity and pulmonary inflammation during antibiotic treatment for tuberculosisHagyu Kim, Eun-Jung Song, Eunsol Choi, et al.
International Journal of Biological Sciences|March 9, 2026
Exploring Host-driven Immunopathological Factors Developing Severe Tuberculosis: Insights from Comparative Mouse ModelsHongmin Kim, Kee Woong Kwon, Hagyu Kim, et al.
Chemico-Biological Interactions|December 17, 2025
Exposure to polyhexamethylene guanidine, a humidifier disinfectant, disrupts protective immunity and accelerates tuberculosis progression via type I IFN signaling and neutrophil influx in miceHagyu Kim, YuJin Shin, Hong-Hee Choi, et al.
Vaccine|February 17, 2024
Immunogenicity and protective efficacy of RipA, a peptidoglycan hydrolase, against Mycobacterium tuberculosis Beijing outbreak strainsKee Woong Kwon, Han-Gyu Choi, Hong-Hee Choi, et al.
Plos Pathogens|August 23, 2024
Permissive lung neutrophils facilitate tuberculosis immunopathogenesis in male phagocyte NADPH oxidase-deficient miceEunsol Choi, Hong-Hee Choi, Kee Woong Kwon, et al.
Nature Communications|October 6, 2025
Mycobacterium tuberculosis-specific T cells restrain anti-cancer drug-induced neutrophilic lung inflammation in tuberculosisKee Woong Kwon, Tae Gun Kang, Jii Bum Lee, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cellular and Molecular Life Sciences : CMLS|September 13, 2023
Revolutionizing control strategies against Mycobacterium tuberculosis infection through selected targeting of lipid metabolismHagyu Kim, Sung Jae Shin
Frontiers in Immunology|June 2, 2020
<i>Mycobacterium tuberculosis</i> Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed TherapyDahee Shim, Hagyu Kim, Sung Jae Shin
Frontiers in Immunology|August 9, 2020
Corrigendum: <i>Mycobacterium tuberculosis</i> Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed TherapyDahee Shim, Hagyu Kim, Sung Jae Shin
NPJ Vaccines|April 10, 2026
An ESAT-6-convergent prime-boost vaccination combining recombinant BCG expressing Mycobacterium marinum ESX-1 and ESAT-6/GLA-SE improves TB protectionKee Woong Kwon, Hongmin Kim, Hagyu Kim, et al.
International Immunopharmacology|April 3, 2024
Adjunctive administration of parabiotic Lactobacillus sakei CVL-001 ameliorates drug-induced toxicity and pulmonary inflammation during antibiotic treatment for tuberculosisHagyu Kim, Eun-Jung Song, Eunsol Choi, et al.
International Journal of Biological Sciences|March 9, 2026
Exploring Host-driven Immunopathological Factors Developing Severe Tuberculosis: Insights from Comparative Mouse ModelsHongmin Kim, Kee Woong Kwon, Hagyu Kim, et al.
Chemico-Biological Interactions|December 17, 2025
Exposure to polyhexamethylene guanidine, a humidifier disinfectant, disrupts protective immunity and accelerates tuberculosis progression via type I IFN signaling and neutrophil influx in miceHagyu Kim, YuJin Shin, Hong-Hee Choi, et al.
Vaccine|February 17, 2024
Immunogenicity and protective efficacy of RipA, a peptidoglycan hydrolase, against Mycobacterium tuberculosis Beijing outbreak strainsKee Woong Kwon, Han-Gyu Choi, Hong-Hee Choi, et al.
Plos Pathogens|August 23, 2024
Permissive lung neutrophils facilitate tuberculosis immunopathogenesis in male phagocyte NADPH oxidase-deficient miceEunsol Choi, Hong-Hee Choi, Kee Woong Kwon, et al.
Nature Communications|October 6, 2025
Mycobacterium tuberculosis-specific T cells restrain anti-cancer drug-induced neutrophilic lung inflammation in tuberculosisKee Woong Kwon, Tae Gun Kang, Jii Bum Lee, et al.
Pageof 1